Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Lorcaserin is a serotonin 5-hydroxytryptamine 2c receptor agonist effective in treating obesity. Studies in rodents have shown that lorcaserin acts in the brain to exert its weight-reducing effects, but this has not yet been studied in humans. We performed a randomized, placebo-controlled, double-bl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes
Main Authors: Farr, Olivia M., Upadhyay, Jagriti, Gavrieli, Anna, Camp, Michelle, Spyrou, Nikolaos, Kaye, Harper, Mathew, Hannah, Vamvini, Maria, Koniaris, Anastasia, Kilim, Holly, Srnka, Alexandra, Migdal, Alexandra, Mantzoros, Christos S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2016
Assuntos:
Obesity Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033259/
https://ncbi.nlm.nih.gov/pubmed/27385157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db16-0635
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados